April 22nd, 2020
| Company Posts

Kerecis Webinar Series: Untreated Wounds – Preparing for COVID-19 Fallout

April 22, 2020 – Kerecis announced today a 3-part webinar series entitled “Untreated Wounds – Preparing for COVID-19 Fallout.” The series will explore best practices in Limb Salvage and how to deal with untreated patients after COVID-19 social constraints are lifted. The series will cover:

April 28, 2020 – Limb Salvage: Acute Infection (Dr. Jonathon Hook, DPM) – Click to Register
May 5, 2020 – Limb Salvage: Lower Extremity Amputation (Dr. Ryan Fitzgerald, DPM) – Click to Register
May 12, 2020 – Limb Salvage: Follow Up and Management (Dr. Patrick McEneaney, DPM) – Click to Register

Latest News

CMS Delays Skin Substitute Policy, Intact Fish-Skin Grafts Remain Covered on Existing LCDs

Learn More

Medical-Fish-Skin Company Kerecis Expands Silicone Fish-Skin Combination Product Range for Surgical and Trauma Wound with SurgiClose® Silicone

Learn More

Kerecis Announces First European Center of Excellence for Medical Fish-Skin Technology

Learn More

CMS Confirms Coverage of Kerecis Fish-Skin Products by Medicare

Learn More

Study Demonstrates Superiority of Kerecis Fish-Skin for Diabetic Foot Ulcer Treatment

Learn More

Kerecis to Present Evidence on Superiority of Fish-Skin Treatment at the Symposium on Advanced Wound Care

Learn More

Kerecis Silicone Fish-Skin Combination for Wound Healing Receives Approval from Palmetto Insurance Group

Learn More

Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions

Learn More

Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy.

Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.

Products

Company

Help